Beta blocker use linked to NSCLC patient survival

Beta blockers may boost survival in patients undergoing definitive radiotherapy for non-small-cell lung cancer, suggests research published in the Annals of Oncology.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news